Top Markets
#1 CoW Protocol CoW Protocol +84.93%
#2 EXOD EXOD +56.80%
#3 Glidr Glidr +38.25%
#4 Walrus Walrus +36.32%
#5 Humanity Humanity +16.84%
#6 Velvet Velvet +16.00%
#7 Cysic Cysic +15.83%
#8 The Black Bull The Black Bull +14.62%
#9 Tutorial Tutorial +14.59%
#10 Plume Plume +14.14%
Coin of the day
CoW Protocol CoW Protocol
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLN
Rankning i aktier #37031
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the... ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.
Aktiekurs
$0.6
Senast synkroniserad: 2024-08-14
Marknadsvärde
$2.09M
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
SG
Handel ASLAN Pharmaceuticals Limited (ASLN)

Kategori

Healthcare
Antal utestående aktier för ASLAN Pharmaceuticals Limited (ASLN)
Antal utestående aktier per March 2024: 4.67M
Enligt de senaste finansiella rapporterna och aktiekursen för ASLAN Pharmaceuticals Limited är det aktuella antalet utestående aktier 4.67M. I slutet av December 2022 hade företaget 3.49M utestående aktier. Antalet utestående aktier påverkas vanligtvis av aktiesplit och återköp av aktier.
Historik över utestående aktier för ASLAN Pharmaceuticals Limited (ASLN) från 2014 till 2026
Utestående aktier vid slutet av varje år
År Utestående aktier Ändra
2026 (TTM) 4.67M 13.50%
2023 4.11M 17.93%
2022 3.49M 7.07%
2021 3.26M 69.43%
2020 1.92M 18.37%
2019 1.62M 8.45%
2018 1.50M 20.35%
2017 1.24M -4.34%
2016 1.30M 136.41%
2015 550.22K 761.10%
2014 63.90K 0.00%
Utestående aktier för liknande företag eller konkurrenter
Företag Utestående aktier Skillnad Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 5,339.61%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 1,232.28%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE